Intuitive Surgical Commences Direct Operations in India

Intuitive Surgical, Inc. (ISRG) has announced the start of direct operations in India through its distributor Vattikuti Technologies Pvt. Ltd.

Post the announcement, Intuitive Surgical’s share price rose 0.3% to close at $454.63. Iin the past six months, shares of the company have rallied 14.6%, significantly outperforming the industry’s decline of 10.2%.

The stock sports a Zacks Rank #1 (Strong Buy).

Notably, Vattikuti provides high technology solutions in healthcare and allied industries and is an authorized distributor of da Vinci surgical systems in India.

Per Vattikuti’s management, the company plans to install a total of 200 da Vinci robots every year in India by 2020, courtesy of its robust demand in the country. Each of the robots costs around $1.2-$2 million. Evidently, this will drive Intuitive Surgical’s overseas revenues significantly.

The Silicon Valley-based pioneer in the field of robotic-assisted, minimally invasive surgery will set up its sixth international headquarters in Bengaluru, India, where employees in sales, marketing, field service engineering, and business operations will support customers throughout the country.

The latest development will not only ascertain wider collaboration opportunities between Intuitive Surgical and India’s surgical community but will also fortify the company’s foothold in Asia.

da Vinci: International Accomplishments

In the last reported quarter, Intuitive Surgical’s OUS (Outside United States) system placements were 73, including 45 in the Europe and nine in Japan.

Internationally, the company continues to enjoy substantial opportunities in Japan, South Korea and China.

The flagship da Vinci system witnessed continued growth in urological procedures in Europe and Asia, and multispecialty growth in China.

Moreover, additional procedures were granted reimbursement by the Ministry of Health in Japan. Additionally, the da Vinci X surgical systems received regulatory clearance from PMDA (Pharmaceuticals and Medical Devices Agency) in Japan and was showcased at a large surgical society meeting, shortly thereafter.

Per management, Intuitive Surgical has installed 68 da Vinci systems so far in India.

 

Market Prospects

Per research by Business Standard, India’s surgical robotics market is estimated to see a CAGR of 20% between 2017 and 2025 to scale to a worth of $350 million, compared with $64.9 million in 2016.

The rising incidence of chronic diseases, increasing geriatric population, growing demand of minimally-invasive surgeries and technological advancements in the field of medical surgeries are some of the factors that are fueling demand for surgical robotic systems.

Hence it can be concluded that Intuitive Surgical’s move has been a timely and strategic one.

Other Key Picks

Some other top-ranked medical stocks are Abiomed, Inc. (ABMD), Varian Medical (VAR) and Baxter International Inc. (BAX).

Abiomed has an expected long-term earnings growth rate of 27%. The stock sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Varian Medical has a projected long-term earnings growth rate of 8%. The stock carries a Zacks Rank #2 (Buy).

Baxter has an expected long-term earnings growth rate of 13.4%. The stock carries a Zacks Rank #2.

Today's Stocks from Zacks' Hottest Strategies

 

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

 

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

 

See Them Free>>

Intuitive Surgical, Inc. (ISRG) has announced the start of direct operations in India through its distributor Vattikuti Technologies Pvt. Ltd.

Post the announcement, Intuitive Surgical’s share price rose 0.3% to close at $454.63. Iin the past six months, shares of the company have rallied 14.6%, significantly outperforming the industry’s decline of 10.2%.

The stock sports a Zacks Rank #1 (Strong Buy).

Notably, Vattikuti provides high technology solutions in healthcare and allied industries and is an authorized distributor of da Vinci surgical systems in India.

Per Vattikuti’s management, the company plans to install a total of 200 da Vinci robots every year in India by 2020, courtesy of its robust demand in the country. Each of the robots costs around $1.2-$2 million. Evidently, this will drive Intuitive Surgical’s overseas revenues significantly.

The Silicon Valley-based pioneer in the field of robotic-assisted, minimally invasive surgery will set up its sixth international headquarters in Bengaluru, India, where employees in sales, marketing, field service engineering, and business operations will support customers throughout the country.

The latest development will not only ascertain wider collaboration opportunities between Intuitive Surgical and India’s surgical community but will also fortify the company’s foothold in Asia.

da Vinci: International Accomplishments

In the last reported quarter, Intuitive Surgical’s OUS (Outside United States) system placements were 73, including 45 in the Europe and nine in Japan.

Internationally, the company continues to enjoy substantial opportunities in Japan, South Korea and China.

The flagship da Vinci system witnessed continued growth in urological procedures in Europe and Asia, and multispecialty growth in China.

Moreover, additional procedures were granted reimbursement by the Ministry of Health in Japan. Additionally, the da Vinci X surgical systems received regulatory clearance from PMDA (Pharmaceuticals and Medical Devices Agency) in Japan and was showcased at a large surgical society meeting, shortly thereafter.

Per management, Intuitive Surgical has installed 68 da Vinci systems so far in India.

 

Market Prospects

Per research by Business Standard, India’s surgical robotics market is estimated to see a CAGR of 20% between 2017 and 2025 to scale to a worth of $350 million, compared with $64.9 million in 2016.

The rising incidence of chronic diseases, increasing geriatric population, growing demand of minimally-invasive surgeries and technological advancements in the field of medical surgeries are some of the factors that are fueling demand for surgical robotic systems.

Hence it can be concluded that Intuitive Surgical’s move has been a timely and strategic one.

Other Key Picks

Some other top-ranked medical stocks are Abiomed, Inc. (ABMD), Varian Medical (VAR) and Baxter International Inc. (BAX).

Abiomed has an expected long-term earnings growth rate of 27%. The stock sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Varian Medical has a projected long-term earnings growth rate of 8%. The stock carries a Zacks Rank #2 (Buy).

Baxter has an expected long-term earnings growth rate of 13.4%. The stock carries a Zacks Rank #2.

Today's Stocks from Zacks' Hottest Strategies

 

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

 

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

 

See Them Free>>

Intuitive Surgical, Inc. ISRG has announced the start of direct operations in India through its distributor Vattikuti Technologies Pvt. Ltd.

 

Post the announcement, Intuitive Surgical’s share price rose 0.3% to close at $454.63. In the past six months, shares of the company have rallied 14.6%, significantly outperforming the industry’s decline of 10.2%.

 

 

The stock sports a Zacks Rank #1 (Strong Buy).

 

Notably, Vattikuti provides high technology solutions in healthcare and allied industries and is an authorized distributor of da Vinci surgical systems in India.

 

Per Vattikuti’s management, the company plans to install a total of 200 da Vinci robots every year in India by 2020, courtesy of its robust demand in the country. Each of the robots costs around $1.2-$2 million. Evidently, this will drive Intuitive Surgical’s overseas revenues significantly.

 

The Silicon Valley-based pioneer in the field of robotic-assisted, minimally invasive surgery will set up its sixth international headquarters in Bengaluru, India, where employees in sales, marketing, field service engineering, and business operations will support customers throughout the country.

 

The latest development will not only ascertain wider collaboration opportunities between Intuitive Surgical and India’s surgical community but will also fortify the company’s foothold in Asia.

 

da Vinci: International Accomplishments

 

In the last reported quarter, Intuitive Surgical’s OUS (Outside United States) system placements were 73, including 45 in the Europe and nine in Japan.

Internationally, the company continues to enjoy substantial opportunities in Japan, South Korea and China.

 

The flagship da Vinci system witnessed continued growth in urological procedures in Europe and Asia, and multispecialty growth in China.

 

Moreover, additional procedures were granted reimbursement by the Ministry of Health in Japan. Additionally, the da Vinci X surgical systems received regulatory clearance from PMDA (Pharmaceuticals and Medical Devices Agency) in Japan and was showcased at a large surgical society meeting, shortly thereafter.

 

Per management, Intuitive Surgical has installed 68 da Vinci systems so far in India.

 

Market Prospects

 

Per research by Business Standard, India’s surgical robotics market is estimated to see a CAGR of 20% between 2017 and 2025 to scale to a worth of $350 million, compared with $64.9 million in 2016.

 

The rising incidence of chronic diseases, increasing geriatric population, growing demand of minimally-invasive surgeries and technological advancements in the field of medical surgeries are some of the factors that are fueling demand for surgical robotic systems.

 

Hence it can be concluded that Intuitive Surgical’s move has been a timely and strategic one.

 

Other Key Picks

 

Some other top-ranked medical stocks are Abiomed, Inc. ABMD, Varian Medical VAR and Baxter International Inc. BAX.

 

Abiomed has an expected long-term earnings growth rate of 27%. The stock sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

 

Varian Medical has a projected long-term earnings growth rate of 8%. The stock carries a Zacks Rank #2 (Buy).

 

Baxter has an expected long-term earnings growth rate of 13.4%. The stock carries a Zacks Rank #2.

 

Today's Stocks from Zacks' Hottest Strategies

 

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

 

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

 

See Them Free>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Varian Medical Systems, Inc. (VAR) : Free Stock Analysis Report
 
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
 
ABIOMED, Inc. (ABMD) : Free Stock Analysis Report
 
Baxter International Inc. (BAX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research